Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two versus three doses of Rotarix in Zambian infants
PACTR201804003096919Completed
- Sponsor
- Center for Infectious Disease Research in Zambia
- Start
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial of human rotavirus RIX4414 strain vaccine in rotaviral diarrhea (2 arms), sponsored by Center for Infectious Disease Research in Zambia. Primary endpoint: Boosting of rotavirus-specific immunoglobulin A antibody responses. Started Mar 2018; status: completed.
02
Drugs
human rotavirus RIX4414 strain vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on PACTR201804003096919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201804003096919.